Contact
Please use this form to send email to PR contact of this press release:
SAR’579 / IPH6101 Receives FDA Fast Track Designation in the US for the Treatment of Hematological Malignancies
TO:
Please use this form to send email to PR contact of this press release:
SAR’579 / IPH6101 Receives FDA Fast Track Designation in the US for the Treatment of Hematological Malignancies
TO: